首页 | 本学科首页   官方微博 | 高级检索  
     

丽珠肠乐及莫沙必利治疗肝衰竭42例
引用本文:李建阳,刘福文,华伟,赵尚知. 丽珠肠乐及莫沙必利治疗肝衰竭42例[J]. 临床肝胆病杂志, 2009, 25(3): 209-210
作者姓名:李建阳  刘福文  华伟  赵尚知
作者单位:蓬安县人民医院,四川,蓬安,637800;蓬安县人民医院,四川,蓬安,637800;蓬安县人民医院,四川,蓬安,637800;蓬安县人民医院,四川,蓬安,637800
摘    要:目的观察丽珠肠乐及莫沙必利治疗慢加急性(亚急性)肝衰竭临床疗效。方法将2003年1月至2007年12月间住院的慢加急性(亚急性)肝衰竭患者随机分为治疗组及对照组,对照组仅给予内科综合治疗,治疗组在此基础上加丽珠肠乐及莫沙必利口服治疗,疗程1月。结果治疗组临床疗效优于对照组(P〈0.01),治疗组治疗后出血、感染、肝性脑病、肝肾综合征、腹水并发症少于对照组。结论丽珠肠乐及莫沙必利治疗慢加急性(亚急性)肝衰竭临床疗效显著,预后明显改善。

关 键 词:丽珠肠乐  莫沙必利  肝衰竭  疗效

Observation of curative effect of Bifidobiogen-Livzon and Mosapride on fouty-two cases with liver failure.
LI Jian-yang,LIU Fu-wen,HUA Wei,et al.. Observation of curative effect of Bifidobiogen-Livzon and Mosapride on fouty-two cases with liver failure.[J]. Chinese Journal of Clinical Hepatology, 2009, 25(3): 209-210
Authors:LI Jian-yang  LIU Fu-wen  HUA Wei  et al.
Affiliation:Pengan Peoples' Hospital;Sichuan;637800 China
Abstract:Objective To observe clinic effect of Bifidobiogen-Livzon and Mosapride on patients with liver failure.Methods 42 cases with subacute liver failure,who were admitted to our hospital from January of 2003 to December of 2007,were randomly divided into two groups(treatment group and control group).The control group was only treated with comprehensive treatment for one month.While for the treatment,besides the comprehensive treatment,Bifidobiogen-Livzon and Mosapride orally were added at the same time.Results T...
Keywords:Bifidobiogen-Livzon  Mosapride  liver failure,curative effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号